C5aR-IN-3
C5aR-IN-3 is a potent inhibitor of C5aR. Increased level of C5a has been associated with disorders such as autoimmune disorders and inflammatory disorders. C5aR-IN-3 has the potential for the research of inflammation diseases (extracted from patent WO2022028586A1, compound 89) [1].
Product Specifications
CAS Number
2761048-50-2
UNSPSC
12352005
Target
Complement System
Type
Reference compound
Related Pathways
Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/c5ar-in-3.html
Solubility
10 mM in DMSO
Smiles
CC1=C(C(F)=CC=C1)C(N2[C@H]([C@H](C[C@H]3CCC[C@H]32)C(NC4=CC5=C(N(N=C5)C)C=C4)=O)C6=CC=C(C=C6)NC7CCOCC7)=O
Molecular Formula
C36H40FN5O3
Molecular Weight
609.73
References & Citations
[1]Gonghua Pan, et al. Compounds as c5ar inhibitors. Patent WO2022028586A1.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
GENLISA™ Rat Cryoglobulin kit (Rat Cryoglobulin kit) ELISA
Recombinant Escherichia coli D-tagatose-1,6-bisphosphate aldolase subunit gatZ (gatZ)
Recombinant Escherichia coli D-tagatose-1,6-bisphosphate aldolase subunit gatZ (gatZ)
Recombinant Escherichia coli D-tagatose-1,6-bisphosphate aldolase subunit gatZ (gatZ)